Novartis US
181 Massachusetts Ave,
Cambridge, 2139, MA,
United States
Cambridge, 2139, MA,
United States
1 862-778-2100
Life Sciences
Novartis US Technographics
Novartis US Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Novartis US and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 15000 Novartis US employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Novartis US has purchased the following applications: Serrala FinanceSuite Accounts Payable for AP Automation in 2015, ADP Enterprise eTIME (OEM Kronos Workforce Central) for Time and Attendance in 2010, H1 HealthCare Data Platform for Analytics and BI in 2018 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Novartis US is running and its propensity to invest more and deepen its relationship with Serrala , Easy Access AP , Stripe or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Novartis US revenues, which have grown to $12.00 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Novartis US intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Novartis US Tech Stack and Enterprise Applications
ERP Financial Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Serrala | Legacy | Serrala FinanceSuite Accounts Payable | AP Automation | ERP Financial Management | n/a | 2015 | 2015 |
In 2015, Novartis US implemented Serrala FinanceSuite Accounts Payable as an AP Automation solution. The deployment supported Novartis Pharmaceuticals work under the Transitional Service Agreement with Elanco following the divestiture of the Animal Health US division, and was used to support fast paced month end close activities including preparation of journal entries, revenue recognition processes, and module reconciliations required for submission to corporate reporting.
Serrala FinanceSuite Accounts Payable was configured to automate core accounts payable workflows, including inbound invoice capture and validation, automated approval routing, exception management, payment scheduling and execution, and generation of AP journal entries for the general ledger. The implementation leveraged AP Automation functional patterns such as three way matching, vendor master synchronization, accrual accounting support, and configurable approval hierarchies to align with Novartis financial controls.
The solution was integrated with Novartis financial systems explicitly referenced in systems knowledge, including SAP Dolphin Production P45 for transactional posting and master data, FCRS Web Collect for submission of consolidated financial results, and NPMR for product margin reporting inputs. Operational coverage focused on the US finance and accounting teams supporting the divested Animal Health business, and the system facilitated structured data handoffs required during the transition to Elanco reporting.
Governance centered on the Transitional Service Agreement and structured knowledge transfer activities, Novartis developed a reconciliation model to map and reconcile Novartis financial reporting to Elanco reporting formats, and participated in knowledge transfer meetings to explain account mapping and reporting details. Serrala FinanceSuite Accounts Payable served as the AP Automation backbone during the transition, supporting control, traceability, and the operational tasks needed to move accounting processes toward Elanco's reporting environment.
|
|
|
|
|
AP Automation | ERP Financial Management |
|
2017 | 2017 |
|
|
|
|
|
Payment Processing | ERP Financial Management |
|
2020 | 2020 |
|
HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| ADP | Legacy | ADP Enterprise eTIME (OEM Kronos Workforce Central) | Time and Attendance | HCM | n/a | 2010 | 2010 |
In 2010, Novartis US implemented ADP Enterprise eTIME (OEM Kronos Workforce Central) as its Time and Attendance solution to reproduce existing timekeeping, scheduling, and absence management workflows. The implementation integrated SAP ECC 6.0 HCM with ADP Enterprise eTIME to align HR master records, time data, and payroll-relevant information across systems.
The project scope covered core Time and Attendance, Scheduling, and Absence Management capabilities, with a focused effort to capture complex pay policies, overtime calculations, and multiple wage rates. Deliverables included complete interface analysis and specifications, mapped As-Is and To-Be business requirements for attendance and pay policies by location, detailed report requirements, and conversion plans for time balances into the ADP environment.
Architecturally the engagement defined a system topology that identified primary source and secondary systems, and established file layouts for uploads to ADP Enterprise eTIME. The integration design specified data extraction by ECC 6.0 HCM infotypes, documented data dependencies and load sequences, and created mapping rules to ensure data consistency between SAP and ADP Enterprise eTIME.
Governance and operational readiness activities included defining service categories, HR master data validation rules, controlling dimensions such as cost center alignment, and setting parameters and controls to analyze master data client files prior to upload. The program also produced a testing strategy and a training strategy to support operational cutover and ongoing use of ADP Enterprise eTIME as the central Time and Attendance application for HR and payroll functions.
|
Analytics and BI
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| H1 Insights | Legacy | H1 HealthCare Data Platform | Analytics and BI | Analytics and BI | n/a | 2018 | 2018 |
In 2018 Novartis US implemented H1 HealthCare Data Platform from vendor H1 Insights to centralize external healthcare intelligence. The H1 HealthCare Data Platform is positioned as an Analytics and BI application to provide unified access to provider, institutional and company-level signals for commercial planning and scientific engagement.
Implementation emphasized core Analytics and BI capabilities within the H1 HealthCare Data Platform including large scale data ingestion and normalization, entity resolution for physicians and organizations, searchable professional profiles, cohort and territory analytics, and interactive visualization for market and KOL analysis. The deployment included configuration of role-based dashboards, standardized reporting templates, and data modeling to support downstream analytics and decision workflows.
Operational scope focused on Novartis US commercial and medical affairs teams, and the platform was used to consolidate intelligence related to external investments and partnerships. The implementation captured and organized information on investments such as Science 37, Cala Health, Aktana, Mekonos, Xealth, Caredox, Freenome, Vineti, H1 Insights and Animantis to support portfolio monitoring and external innovation scouting.
Governance practices were established to manage access, data stewardship and standardized consumption of insights, with procedures for report ownership and cross-functional handoffs to commercial, medical and portfolio teams. The program oriented workflows around centralized Analytics and BI outputs from H1 HealthCare Data Platform to improve consistency of external company and provider intelligence across Novartis US.
|
Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Collaboration | Collaboration |
|
2020 | 2020 |
|
|
|
|
|
Event Management | Collaboration |
|
2015 | 2015 |
|
Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Web Content Management | Content Management |
|
2020 | 2020 |
|
CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
CRM | CRM |
|
2011 | 2011 |
|
|
|
|
|
Marketing Analytics | CRM |
|
2020 | 2020 |
|
ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Performance Management | ITSM |
|
2021 | 2021 |
|
PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Robotic Process Automation | PaaS |
|
2016 | 2016 |
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Archive as a Service (AaaS) | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Backup as a Service (BaaS) | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Disaster Recovery as a Service (DRaaS) | IaaS |
|
2019 | 2019 |
|
IT Decision Makers and Key Stakeholders at Novartis US
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Novartis US Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Novartis US IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Novartis US digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Novartis US Technographics
Novartis US is a Life Sciences organization based in United States,
with around 15000 employees and annual revenues of $12.00 billion.
Novartis US operates a diverse technology stack with applications such as
Serrala FinanceSuite Accounts Payable, ADP Enterprise eTIME (OEM Kronos Workforce Central) and H1 HealthCare Data Platform,
covering areas like AP Automation, Time and Attendance and Analytics and BI.
Novartis US has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Serrala, ADP and H1 Insights.
Novartis US recently adopted applications including
New Relic APM in 2021, Cloudflare CDN in 2021 and Akamai CDN in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Novartis US’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Novartis US’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Novartis US technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.